89 results
Page 3 of 5
8-K
6sctdctynwpp607kcjm
13 Dec 18
Millendo Therapeutics Announces Successful Merger Completion
4:08pm
DEFM14A
3169 li3iu46
6 Nov 18
Proxy related to merger
12:00am
424B3
wuqxf
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
y4g01behfh50cz9f43l
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-3.1
oeind7t n3pd
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.1
kayr1
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-3.1
dxm230
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.1
xf2dg2lkpe5d5k do
9 Aug 18
Business combination disclosure
5:17pm
8-K
uspudv1 15m3aj10mvjg
23 Dec 16
OvaScience Announces Business Update
12:00am
8-K
EX-3.1
6kyhr qgd4l
23 Dec 16
OvaScience Announces Business Update
12:00am
8-K
diu pjf9feo27x6qa
24 Dec 14
Departure of Directors or Certain Officers
12:00am